The Company’s initial public offering comprises an offer for sale of shares aggregating up to Rs7,50crore with face value Rs10 each by selling shareholders.
The offer for sale comprises of equity shares aggregating up to Rs525 crore by Sanjay Bharatkumar Jaiswal and equity shares aggregating up to Rs225 crore by Ashima Sanjay Jaiswal (collectively, The “Promoter Selling Shareholders”).
The company is among the pioneers to facilitate the penetration of on premise PSA oxygen generators in Indian hospitals with nearly 872 installed and operational PSA oxygen generators, as of March 31, 2022.
The company has been able to capture and penetrate the Indian medical oxygen generation market to become a market leader with around 30-31% of market share as of Fiscal 2022, in terms of total installed operational PSA oxygen generators in India, which includes both government and public sector hospital PSA medical oxygen market.
JM Financial Limited and ICICI Securities Limited are the Book Running Lead Managers to the issue.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.